Online citations, reference lists, and bibliographies.
← Back to Search

Preparation And Characterization Of Cationic PLGA Nanospheres As DNA Carriers.

M. Ravi Kumar, U. Bakowsky, C. Lehr
Published 2004 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Nanoparticles formulated from biodegradable polymers such as poly(lactic acid) (PLA) and poly(lactide-co-glycolide) (PLGA) are being extensively investigated as non-viral gene delivery systems due to their controlled release characteristics and biocompatibility. PLGA nanoparticles for DNA delivery are mainly formulated by an emulsion-solvent evaporation technique using PVA as a stabilizer generating negatively charged particles and heterogeneous size distribution. The objective of the present study was to formulate cationically modified PLGA nanoparticles with defined size and shape that can efficiently bind DNA. An Emulsion-diffusion-evaporation technique to make cationic nanospheres composed of biodegradable and biocompatible co-polyester PLGA has been developed. PVA-chitosan blend was used to stabilize the PLGA nanospheres. The nanospheres were characterized by atomic force microscopy (AFM), photon-correlation spectroscopy (PCS), and Fourier transform infrared spectroscopy (FTIR). Zeta potential and gel electrophoresis studies were also performed to understand the surface properties of nanospheres and their ability to condense negatively charged DNA. The designed nanospheres have a zeta potential of 10mV at pH 7.4 and size under 200nm. From the gel electrophoresis studies we found that the charge on the nanospheres is sufficient to efficiently bind the negatively charged DNA electrostatically. These cationic PLGA nanospheres could serve as potential alternatives of the existing negatively charged nanoparticles.
This paper references
10.1016/S0168-3659(00)00364-3
Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.
S. Feng (2001)
Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.
A. Lamprecht (2001)
10.1016/S0378-5173(02)00315-0
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.
S. Prabha (2002)
10.1023/A:1011929016601
Chitosan and its use as a pharmaceutical excipient.
L. Illum (1998)
10.1016/S0168-3659(97)00106-5
Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.
M. Zambaux (1998)
10.1016/S0031-6865(97)00021-6
Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations.
V. Baeyens (1997)
10.3109/02652049809006840
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique.
D. Quintanar-Guerrero (1998)
10.1096/fj.02-0088com
Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery
J. Panyam (2002)
10.1016/S0168-3659(02)00127-X
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
S. Sahoo (2002)
10.1016/S0168-3659(01)00487-4
A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides.
D. M. Schachter (2002)
10.1016/S0927-7757(01)01042-1
Thermodynamic parameters on poly(d,l-lactide-co-glycolide) particle size in emulsification–diffusion process
S. Choi (2002)
10.3109/03639048109055684
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
R. Gurny (1981)
10.1016/0378-5173(89)90281-0
Nanocapsule formation by interfacial polymer deposition following solvent displacement
H. Fessi (1989)
10.1016/S0939-6411(02)00128-5
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy.
Y. Konan (2003)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
10.1038/sj.gt.3301830
Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis
H. Cohen-Sacks (2002)
10.1016/S0168-3659(98)00097-2
Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery.
F. Maclaughlin (1998)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1016/S0378-5173(99)00107-6
Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification.
A. Lamprecht (1999)
10.1038/sj.gt.3301492
Chitosan as a nonviral gene delivery system. Structure–property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo
M. Köping-Höggård (2001)
10.1016/0168-3659(93)90097-O
Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior.
T. Niwa (1993)
10.1016/S0378-5173(96)04854-5
Influence of the Degrees of Hydrolyzation and Polymerization of Poly(vinylalchol)on the Preparation and Properties of Poly(DL-lactide-co-glycolide)nanoparticle.
Murakami (1997)
10.1016/0142-9612(96)00049-X
Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).
D. Lemoine (1996)
10.1016/S0378-5173(02)00058-3
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
J. Vandervoort (2002)
10.1016/0378-5173(92)90249-2
Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size
E. Allémann (1992)



This paper is referenced by
10.1080/10611860600565987
Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration
I. Bala (2006)
10.1007/978-1-4020-5041-1_9
Synthetic Vectors for Genetic Drug Delivery
P. Wyrozumska (2006)
10.3390/pharmaceutics6030378
Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives
Yingying Xu (2014)
10.1177/0885328207077415
Preparation and Characterization of Cationic Chitosan-modified Poly(D,L-lactide-co-glycolide) Copolymer Nanospheres as DNA Carriers
Xi-Peng Guan (2008)
10.1680/JBIBN.15.00016
Chitosan-functionalized poly(lactide-co-glycolide) nanoparticles: breaking through the brain’s tight security gateway
JalaliN. (2016)
10.1163/156856206778667442
Nanobiomaterials: a review of the existing science and technology, and new approaches
V. Hasirci (2006)
10.1039/C0PY00210K
Synthetic polymers for biopharmaceutical delivery
J. Magnusson (2011)
10.1007/s11095-005-8418-y
Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy
S. Hariharan (2005)
In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells.
Tugce Dastan (2004)
10.3389/fmats.2018.00014
Harnessing the Potential of Biomaterials for Brain Repair after Stroke
Anup Tuladhar (2018)
10.1093/abbs/gmr082
Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B.
N. Giri (2011)
10.1016/B978-1-4557-0737-9.00036-9
Chapter 36 – Nanomedicine in Ophthalmology
M. Zarbin (2013)
UPDATED REVIEW ON NANOPARTICLES AS DRUG DELIVERY SYSTEMS
Audumbar Digambar Mali (2015)
10.1088/1748-6041/3/3/034114
Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis.
Rajeev Raghavan Pillai (2008)
Pozaustrojowe badania nad toksycznym oddziaływaniem kopolimeru PLGA z dodatkiem hydroksyapatytu na ludzkie osteoblasty linii hFOB 1.19
Mariusz Cieślik (2009)
10.1039/B913767J
One-step pyrolysis method for the synthesis of highly efficient 3D hollow carbon nanostructure supported metallic catalysts
Y. Ding (2009)
10.1167/iovs.10-6916
AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.
Zongchao Han (2011)
10.1007/S11434-012-5052-Z
RETRACTED ARTICLE Recent progress in AFM studies of biodegradable poly(lactic acid) materials
Chao Zeng (2012)
10.4164/SPTJ.49.758
Interaction of Biodegradable Nnanoparticles for Drug Delivery with Cells
Kohei Tahara (2012)
10.1088/2053-1591/3/12/125403
Factorial design based preparation, optimization, characterization and in vitro drug release studies of olanzapine loaded PLGA nanoparticles
Sarvesh Bohrey (2016)
10.1063/1.5012535
Controlled and localized delivery of c-myc AS-ODN to cells by 3-aminopropyl-trimethoxylsilane modified SBA-15 mesoporous silica
Juan Zhang (2018)
Porównanie właściwości biologicznych czystego i napełnionego hydroksyapatytem kopolimeru glikolidu z laktydem
M. Cieślik (2006)
10.1163/156856206778937217
Characterization of particles fabricated with poly(D,L-lactic-co-glycolic acid) and an ornithine–histidine peptide as carriers of oligodeoxynucleotide for delivery into primary dendritic cells
Y. Zheng (2006)
10.1021/mp3005534
trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity.
A. Gomes (2013)
10.13130/cella-claudia_phd2016-03-18
Development of biodegradable nanoparticles for targeting Tumor Associated Macrophages: synthesis, investigation of the role of the surfactant and surface decoration in complex media
C. Cella (2016)
10.1163/156856206775997322
Synthesis and characterization of PLGA nanoparticles
C. Astete (2006)
10.1088/0957-4484/18/30/305305
Microfluidic assisted preparation of CdSe/ZnS nanocrystals encapsulated into poly(DL-lactide-co-glycolide) microcapsules
Jia-Yaw Chang (2007)
10.1016/J.COLSURFB.2007.05.011
Fabrication, in vitro degradation and the release behaviours of poly(DL-lactide-co-glycolide) nanospheres containing ascorbic acid.
M. Stevanović (2007)
10.1016/j.ejpb.2008.07.011
The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
S. Taetz (2009)
10.2147/IJN.S43251
Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines
Huijie Zhang (2013)
10.1080/00914037.2013.853665
A Novel of Biodegradable Implants Based on PLGA for Control Delivery of Cisplatin
W. Li (2014)
10.1039/C4RA06144F
Employment of nanomaterials in polymerase chain reaction: insight into the impacts and putative operating mechanisms of nano-additives in PCR
Meral Yüce (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar